The class of chemicals that can be considered as indirect activators of CNPY1 primarily consists of compounds that modulate the FGF (Fibroblast Growth Factor) signaling pathway. FGF signaling is a complex and crucial pathway involved in various cellular processes such as cell growth, survival, migration, and differentiation. CNPY1, as part of this pathway, plays a role in regulating its activities, although the exact mechanisms of its action are not fully elucidated.
The chemicals listed above include growth factors, tyrosine kinase inhibitors, and other molecules that either enhance or inhibit components of the FGF signaling pathway. Compounds like FGF-2 and Heparin function by directly stimulating the pathway, leading to an upregulation of CNPY1 as part of the regulatory response. On the other hand, inhibitors like This indirect modulation of the pathway can result in changes in CNPY1 activity, given its role in the pathway. Kinase inhibitors such as Nintedanib, have a broader target profile, including FGFRs, and their impact on FGF signaling and consequently on CNPY1 is more complex. These inhibitors can lead to a reduction in FGF signaling, affecting the regulatory functions of CNPY1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Heparin | 9005-49-6 | sc-507344 | 25 mg | $119.00 | 1 | |
Heparin, while primarily known as an anticoagulant, also binds to FGF and its receptors, enhancing FGF signaling which could indirectly affect CNPY1. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $213.00 $359.00 | 3 | |
LY2157299 inhibits TGF-β receptor kinase, which interacts with FGF signaling pathways, potentially influencing CNPY1. | ||||||